Exozymes Inc (EXOZ)

Sep 24, 2026

eXoZymes, Inc. (EXOZ) stock price, news, quote and history - Yahoo Finance UK

Sep 24, 2026

Sep 18, 2026

Form 8K eXoZymes Inc For: 18 September By Investing.com - Investing.com Nigeria

Sep 18, 2026

Sep 18, 2026

Exozymes sets date for 2026 annual meeting and announces record date - Investing.com

Sep 18, 2026

Sep 17, 2026

EXOZ: eXoZymes Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 17, 2026

Sep 17, 2026

Exozymes (EXOZ) grants VP 45,000 stock options - Stock Titan

Sep 17, 2026

Sep 15, 2026

EXOZ 424B FilingseXoZymes Inc. SEC 424B - Stock Titan

Sep 15, 2026

Sep 15, 2026

EXOZ 8-K FilingseXoZymes Inc. SEC 8-K - Stock Titan

Sep 15, 2026

Sep 09, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Sep 09, 2026

Sep 08, 2026

eXoZymes (EXOZ) Stock: Curia Deal Moves NCT Toward Commercial Production - Blockonomi

Sep 08, 2026

Sep 08, 2026

exozymes partners with Curia for NCT manufacturing scale-up By Investing.com - Investing.com Nigeria

Sep 08, 2026

Sep 08, 2026

exozymes partners with Curia for NCT manufacturing scale-up - Investing.com

Sep 08, 2026

Sep 08, 2026

eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT - The Joplin Globe

Sep 08, 2026

Sep 08, 2026

A 3,000-employee manufacturer will help eXoZymes move a product toward larger-scale production. - Stock Titan

Sep 08, 2026

Sep 03, 2026

Exozymes CEO Michael Heltzen buys $6,405 in company stock By Investing.com - Investing.com South Africa

Sep 03, 2026

Sep 02, 2026

Exozymes CEO Michael Heltzen buys $6,405 in company stock - Investing.com

Sep 02, 2026

Sep 02, 2026

Exozymes (EXOZ) CEO adds stock with August buys and grant - stocktitan.net

Sep 02, 2026

Sep 02, 2026

eXoZymes Inc. (EXOZ) Edges Lower, Holding Support at $6.13 After 0.77% DipNAAIM Exposure - dars.gov.et

Sep 02, 2026

Aug 31, 2026

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO - Barchart.com

Aug 31, 2026

Aug 30, 2026

eXoZymes Provides Fourth Quarter and Full Year 2024 Update - Barchart.com

Aug 30, 2026

Aug 28, 2026

eXoZymes Inc. (EXOZ) Holds Near $7.17 as Shares Trade Within Established RangePut Dominated - vinanet.vn

Aug 28, 2026

Aug 25, 2026

Primer: eXoZymes (EXOZ US)Aug 2026 - Smartkarma

Aug 25, 2026

Aug 25, 2026

Exozymes (EXOZ) CSO adds 32,964 shares from RSU vesting - Stock Titan

Aug 25, 2026

Aug 21, 2026

EXoZymes Inc (EXOZ) (Q2 2026) Earnings Call Highlights: Strategic Pivot and 10x Productivity ... - Yahoo Finance

Aug 21, 2026

Aug 20, 2026

eXoZymes (EXOZ): Ends Up by 10.00% at $7.04; Trading Range: the Near-Term Reference Band Stretches From $6.69 to $7.39 in the Available RecordKey Reversal Day - vinanet.vn

Aug 20, 2026

Aug 20, 2026

eXoZymes Q2FY26 Results: Net loss widens to $2.88M, raises $6M - scanx.trade

Aug 20, 2026

Aug 20, 2026

eXoZymes Q2 Earnings Call Highlights - Yahoo Finance

Aug 20, 2026

Aug 20, 2026

Earnings call transcript: eXoZymes posts q2 2026 loss as launch plans advance - Investing.com

Aug 20, 2026

Aug 20, 2026

EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization - TradingView

Aug 20, 2026

Aug 20, 2026

eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today - The Batesville Daily Guard

Aug 20, 2026

Aug 18, 2026

exoZymes reports 10-fold productivity gain in NCT manufacturing By Investing.com - Investing.com Canada

Aug 18, 2026

Aug 18, 2026

eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - ACCESS Newswire

Aug 18, 2026

Aug 18, 2026

EXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - marketscreener.com

Aug 18, 2026

Aug 16, 2026

Will eXoZymes (NASDAQ:EXOZ) Spend Its Cash Wisely? - webull.com

Aug 16, 2026

Aug 15, 2026

eXoZymes Inc. (EXOZ) Drops 3% to $5.82, Pressuring Key Support at $5.53Narrow Range Breakout - vinanet.vn

Aug 15, 2026

Aug 13, 2026

MDB Capital Holdings (MDBH) records $16.1M H1 2026 loss and $33.1M eXoZymes stake - Stock Titan

Aug 13, 2026

Aug 13, 2026

EXOZYMES INC. 2Q 2026: Revenue $0 Net loss $(5.25M) — 10-Q Summary - TradingView

Aug 13, 2026

Aug 13, 2026

EXoZymes, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Aug 13, 2026

EXOZ 10-Q FilingseXoZymes Inc. SEC 10-Q - Stock Titan

Aug 13, 2026

Aug 12, 2026

eXoZymes Inc (EXOZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 12, 2026

Aug 12, 2026

eXoZymes Q2 Results: Update call scheduled for August 20 - scanx.trade

Aug 12, 2026

Aug 11, 2026

eXoZymes CEO to Lead Q2 Results Webinar With Q&A Aug. 20 - Stock Titan

Aug 11, 2026

Aug 11, 2026

eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026 - ACCESS Newswire

Aug 11, 2026

Aug 10, 2026

eXoZymes Inc. (EXOZ) Climbs 3.92% to $5.3 as Biotech Stock Approaches Key ResistancePut Spread Alert - dars.gov.et

Aug 10, 2026

Aug 07, 2026

eXoZymes Inc (EXOZ) Stock News Today - TradingKey

Aug 07, 2026

Aug 03, 2026

eXoZymes (EXOZ) Slides 5.15% to $4.6 as Biotech Selling Pressure IntensifiesBuyback Factor - careplusvn.com

Aug 03, 2026

Jul 28, 2026

eXoZymes Inc. (EXOZ) Slips 1.1% as Shares Test Support Near $4.27Risk Reversal - vinanet.vn

Jul 28, 2026

Jul 28, 2026

eXoZymes Inc (EXOZ) Income Statement - TradingKey

Jul 28, 2026